{"name":"Alesta Therapeutics","slug":"alesta-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxQZ0M3a0cxZEpZSGxPUEN4QmROc2JEM0RHeE1BdkNvRnZnYjRrRzJQV1pLVmNsVkhZcWZjMEdSLUVRUGpfV1lIX0NNTTM2MU94OHdVSXF0T1lJWXRnZVVJMzE0Mmdyd2FuTGxYRDZOc3Z3aVBhX2RodDdWam9JWGhHWWVySDdKVDR0Qk5DTGpDdEFRQQ?oc=5","date":"2026-01-06","type":"pipeline","source":"Yahoo Finance UK","summary":"Alesta to Highlight ALE1 Clinical Progress at 44th Annual JP Morgan Healthcare Conference - Yahoo Finance UK","headline":"Alesta to Highlight ALE1 Clinical Progress at 44th Annual JP Morgan Healthcare Conference","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxOQkxmbk12TjRSRXhEVnFZTGotcy1sUlZsYXdPSTNBeV9BTk40QnJraDBzeHppNGpuR0JLVmk3TV82a0drdXhTdUpGOTgzMk5DbVdlclZYMTQzSzlfelE1eTdwYXpGVXBNMzV6eW05ZjBPLTFTMHF5TUNscEVlTkhqWQ?oc=5","date":"2025-12-19","type":"pipeline","source":"Fierce Biotech","summary":"Fierce Biotech Fundraising Tracker '25: Atavistik adds $120M; Syneron Bio secures new funds - Fierce Biotech","headline":"Fierce Biotech Fundraising Tracker '25: Atavistik adds $120M; Syneron Bio secures new funds","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTE5PNktRSGpwTkM2Mno5MTBpQnM1VWJsZjZTc18xX3dZYzJFV0xUSTdEdFNscFJNVGN2YVVhTF93bnR6bXdlUW81Tl85dzZUaUpSS0xvUkcwNjJIY1NVSjQ1RzVLWXVDUFY2YzVBdHZveV9TQQ?oc=5","date":"2025-07-24","type":"pipeline","source":"Labiotech.eu","summary":"Which biotech companies are gaining traction in genetic diseases? - Labiotech.eu","headline":"Which biotech companies are gaining traction in genetic diseases?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPSW1lSmJPMTQ5Rjc1TWpUNmRqOVR1cXFpMC1ING53dW5pTjRNd09IMlR4R0ZVdm9yZGlaQy16NlZjWVExM1VKWW1TRGpFNFMwczgydlVoTHhGc2pjb01LRF9WVk1YZUVNRFdER0M1Mm0zTm5LRjZDVWdnSXRJaVlmY2RUNzU0akRPQ19VVlFXSDBINXdrZUtLMEFSX1gyQy1Lc3c?oc=5","date":"2025-07-08","type":"pipeline","source":"Fierce Biotech","summary":"Rallybio shifts gears, cashing out of Recursion pact to extend runway - Fierce Biotech","headline":"Rallybio shifts gears, cashing out of Recursion pact to extend runway","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTFBvR1lYUGhocUpQZFIyNkUya04xV1RrRmdILThRdTB6Ui1ka1VZVlVld1J1cDJ2QXRyRmNJTC1fVDRZTV9WX2V3UUVlbmpJM2lvcm5MMVEySHB5T01nWTF4anQ5QnJvbjNFdk5ZQ0FFMUZUQUdjVkpJ?oc=5","date":"2025-04-07","type":"pipeline","source":"Silicon Canals","summary":"On World Health Day, meet the Dutch healthtech startups that raised funding in 2025; 5 of them are hiring - Silicon Canals","headline":"On World Health Day, meet the Dutch healthtech startups that raised funding in 2025; 5 of them are hiring","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxNR3VPRWdnWXIzSXE0V2xQWHB4LW1KaFhyOVhGZ3hlNm9KdUJmWTlJTFgwZnZLb3VQMnlUYjZTU2JwWFg3MFU2b1h1ZW1CU0tISkJCa2dxaVR3aDVtSmZMYTBFUndrV2ZTcmthTjBmYXRxS3Z1TE9JS2ZxZXBQeHVXZ0FxN3BMZlhnQXJZ?oc=5","date":"2025-01-17","type":"pipeline","source":"pharmaphorum","summary":"Kardigan raises $300m for cardio work, and other financings - pharmaphorum","headline":"Kardigan raises $300m for cardio work, and other financings","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwJBVV95cUxObGFJSVZJOXRtTllmYTVycVBEZnR6S3JLUHQyNnRyeFd5VlhvMDktRm01d1JFY2xRVTFWWjVLVWJrMTE3OFc1YWJDYlM5ak13b0tOdkN4ZDI4d0hGY2sxbHV1b2FLcTNnaGhpNWdiSWs5NU8zWGpRWDRHWmZ5ZExyUHBabHlwaHpMNkN2VTlnc0N2R1hjeWZKc3VKbGNKMzFjVUJlVzVta3YxdTdja0VuRkxXVWhxVkxjaXNDZVlMaV9xUU9KWkVBS2lPQWlxOVg1WlhoOGpVQ00xbG9NdmNDdUZLMGhHbjZBazlMOHZVcnh2RU1BRnZqb0ZYcW54ZFQ4N3FZaDRmODEwa1hzbVVNZ3A1WEJrTnFQblhlMGlOUWwxRkZIb3p4RHV5YjAwcnc?oc=5","date":"2025-01-08","type":"pipeline","source":"PR Newswire","summary":"1cBio and Alesta Therapeutics Announce Exclusive Global Licensing Agreement for a Novel Potentially First-in-Class Small Molecule for Hypophosphatasia - PR Newswire","headline":"1cBio and Alesta Therapeutics Announce Exclusive Global Licensing Agreement for a Novel Potentially First-in-Class Small","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE1zQnlSOWoyemUwTlJqYjBIcnZ3cTBLZ1E2Qlg4amNKRDIwVVNKMU1HaEJtVy1kM0Y1ekVxTnFSWFJvdDZfY1g4SDNDRU5MSnBELWZz?oc=5","date":"2025-01-08","type":"pipeline","source":"FirstWord Pharma","summary":"New year starts with a bang as trio of venture financings brings in $382M - FirstWord Pharma","headline":"New year starts with a bang as trio of venture financings brings in $382M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9AFBVV95cUxPWGZLV1drNVhOazZPMTlMYU81ZkxQMkotYkxDd19zME92dUo0cHhVaFAxXzVWX0ZZM3V4STgxa2RGVUt6ZVE1Wjc2WHYteGlqV2NKZVVzTXlfeHNha0VsVHl1RWRiOGR5TnBKdTFVa1RkYVBUd3Z0cE5pVUJHZUZxb2YzSE5sOWVHc3FjTmZzSHhEWFQwc2lBcjZlYk1aR3A0UjdWVDhaN1hIb2RXUk8wN0lXUk1qT182MW5jS2pMb1AzcWxhd2xFUFZEOFF0ZVVmWXhJWUh6cHRyNnlzVEpiYmJKMklkOS01UzljWWZLc1RnZVVH?oc=5","date":"2025-01-08","type":"pipeline","source":"PR Newswire","summary":"Alesta Therapeutics Raises €65 Million Series A Financing to Advance Oral Small Molecules for Rare Diseases - PR Newswire","headline":"Alesta Therapeutics Raises €65 Million Series A Financing to Advance Oral Small Molecules for Rare Diseases","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}